Release Date: November 26, 2024

Expiration Date: November 26, 2025

Activity Overview

This Community Practice Connections™ program provides an in-depth review of some of the highlights from the 6th Annual Precision Medicine Symposium: An Illustrated Tumor Board that was held in October 2024. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of applying precision medicine to the care of patients with solid tumors and hematologic malignancies, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Target Audience

This educational activity is directed toward medical oncologists, hematologists, nurses, and pathologists. Nurse practitioners, physician assistants, pharmacists, researchers, and other healthcare professionals may also participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Assess evidence supporting the use of biomarkers for risk stratification and prognostic assessment across cancer types
Interpret clinical trial readouts in the context of how testing for actionable genomic alterations should be implemented among patients with cancer
Explain how specific genomic alterations and biomarkers can be leveraged to inform risk stratification and treatment planning in cancer
Apply multidisciplinary decision-making in the assessment and application of genomic testing results along the cancer care continuum

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Pfizer Inc.

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

GET STARTED WITH THIS PROGRAM:

Related Content

Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Wisconsin Association of Hematology and Oncology

Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Missouri Oncology Society

Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Nevada Oncology Society

Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | The Arizona Clinical Oncology Society